Rubric Capital Management (New York)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $436M | Buy |
|
|||||
|
2025
Q1 | $393M | Buy |
|
|||||
|
2024
Q4 | $375M | Buy |
|
|||||
|
2024
Q3 | $288M | Sell |
|
|||||
|
2024
Q2 | $281M | Sell |
|
|||||
|
2024
Q1 | $249M | Sell |
|
|||||
|
2023
Q4 | $190M | Sell |
|
|||||
|
2023
Q3 | $194M | Buy |
|
|||||
|
2023
Q2 | $141M | Buy |
|
|||||
|
2023
Q1 | $39.8M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $12.8M | Buy |
|